Literature DB >> 10504009

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

M Haack1, D Hinze-Selch, T Fenzel, T Kraus, M Kühn, A Schuld, T Pollmächer.   

Abstract

It has been hypothesized that the immune system plays a pathogenetic role in psychiatric disorders, in particular in major depression and schizophrenia. This hypothesis is supported by a number of reports on altered circulating levels and in vitro production of cytokines in these disorders. However, the respective evidence is not consistent. This may be in part due to an incomplete control for numerous confounding influences in earlier studies. We investigated the plasma levels of cytokines and soluble cytokine receptors in psychiatric patients (N = 361) upon hospital admission and compared the results to those obtained in healthy controls (N = 64). By multiple regression analysis we found that circulating levels of interleukin-1 receptor antagonist (IL-1Ra), soluble IL-2 receptor (sIL-2R), tumor necrosis factor-alpha (TNF-alpha), soluble TNF receptors (sTNF-R p55, sTNF-R p75) and IL-6 were significantly affected by age, the body mass index (BMI), gender, smoking habits, ongoing or recent infectious diseases, or prior medication. Cytokine or cytokine receptor levels were significantly increased in patients treated with clozapine (sIL-2R, sTNF-R p75), lithium (TNF-alpha, sTNF-R p75, IL-6) or benzodiazepines (TNF-alpha, sTNF-R p75). Taking all these confounding factors into account, we found no evidence for disease-related alterations in the levels of IL-1Ra, sIL-2R, sTNF-R p75 and IL-6, whereas levels of TNF-alpha and sTNF-R p55 in major depression and sTNF-R p55 in schizophrenia were slightly decreased compared to healthy controls. We conclude that, if confounding factors are carefully taken into account, plasma levels of the above mentioned cytokines and cytokine receptors yield little, if any, evidence for immunopathology in schizophrenia or major depression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504009     DOI: 10.1016/s0022-3956(99)00021-7

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  72 in total

Review 1.  Pharmacogenetics of antipsychotic-induced weight gain.

Authors:  Christoph U Correll; Anil K Malhotra
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

2.  Cytokine profile in patients undergoing minimally invasive surgery with balanced anesthesia.

Authors:  José Eduardo B Orosz; Mariana G Braz; Márjorie A Golim; Márcio Antônio A Barreira; Denise Fecchio; Leandro G Braz; José Reinaldo C Braz
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

3.  Chronic variable stress alters inflammatory and cholinergic parameters in hippocampus of rats.

Authors:  Bárbara Tagliari; Ana Paula Tagliari; Felipe Schmitz; Aline A da Cunha; Carla Dalmaz; Angela T S Wyse
Journal:  Neurochem Res       Date:  2010-12-24       Impact factor: 3.996

4.  The psychomodulatory action of subpyrogenic doses of interleukin-1beta in conditions of chronic administration to rats.

Authors:  E S Sokolova; V I Lyudyno; A S Simbirtsev; V M Klimenko
Journal:  Neurosci Behav Physiol       Date:  2007-06

5.  Comparison of inflammatory cytokine profiles in plasma of patients undergoing otorhinological surgery with propofol or isoflurane anesthesia.

Authors:  Marina Azer Mazoti; Mariana Gobbo Braz; Márjorie de Assis Golim; Leandro Gobbo Braz; Norimar Hernandes Dias; Daisy Maria Favero Salvadori; José Reinaldo Cerqueira Braz; Denise Fecchio
Journal:  Inflamm Res       Date:  2013-06-22       Impact factor: 4.575

6.  Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.

Authors:  Izabela Guimarães Barbosa; Rodrigo Barreto Huguet; Vanessa Amaral Mendonça; Lirlândia Pires Sousa; Fernando Silva Neves; Moisés Evandro Bauer; Antônio Lúcio Teixeira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-05-06       Impact factor: 5.270

7.  Immune System and Schizophrenia.

Authors:  Norbert Müller; Markus J Schwarz
Journal:  Curr Immunol Rev       Date:  2010-08

Review 8.  COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date.

Authors:  Michael Riedel; Martin Strassnig; Markus J Schwarz; Norbert Müller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

9.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

Review 10.  Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).

Authors:  Eléonore Beurel; Suzanne M Michalek; Richard S Jope
Journal:  Trends Immunol       Date:  2009-10-14       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.